Ani pharmaceuticals, inc. announces pricing of $75 million public offering of common stock

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (nasdaq: anip) (“ani” or the "company") today announced the pricing of an underwritten public offering of 1,500,000 shares of its common stock at a public offering price of $50.00 per share. the gross proceeds of the offering to the company are expected to be $75 million, before deducting the underwriting discounts and commissions and other offering expenses. in addition, ani granted the underwriters a 30-day option to purchase up to a
ANIP Ratings Summary
ANIP Quant Ranking